15.72

0.60% -0.095

After Hours: 15.71 -0.010 -0.06%

Rallybio Corp (RLYB)

Overview News Price History Financials Discussions Forecast

Rallybio Corp stock is traded at $15.72, with a volume of 19,102. It is down -0.60% in the last 24 hours and down -1.44% over the past month. Rallybio Corp is a clinical-stage biotechnology company comprised of experienced biopharma industry leaders with extensive research, development, and rare disease expertise with a mission to develop and commercialize life-transforming therapies for patients with severe and rare diseases. The company's program, RLYB116, is a differentiated complement component 5 (C5) inhibitor with the potential to treat diseases of complement dysregulation. The Company manages its operations as a single segment for the purposes of allocating resources, assessing performance, and making operating decisions. Rallybio's pipeline also includes RLYB332, a preclinical long-acting matriptase-2 antibody for the treatment of diseases of iron overload.

Previous Close:

$15.81

Open:

$15.73

24h Volume:

19,102

Relative Volume:

0.08

Market Cap:

$91.18M

Revenue:

$858.00K

Net Income/Loss:

$-7.82M

P/E Ratio:

-10.84

EPS:

-1.4503

Net Cash Flow:

$-27.59M

1W Performance:

-2.12%

1M Performance:

-1.44%

6M Performance:

+189.44%

1Y Performance:

+490.62%

1-Day Range:

$15.70

$15.95

1-Week Range:

$15.70

$16.25

52-Week Range:

$2.6632

$17.57

Rallybio Corp Stock (RLYB) Company Profile

Name

Rallybio Corp

Sector

Healthcare (1100)

Industry

Biotechnology (615)

Phone

203- 859-3820

Address

234 CHURCH STREET, NEW HAVEN

Employee

Twitter

Next Earnings Date

2026-08-06

Latest SEC Filings

RLYB's Discussions on Twitter

Compare RLYB vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
RLYB Rallybio Corp	15.72	92.80M	858.00K	-7.82M	-27.59M	-1.4503
VRTX Vertex Pharmaceuticals Inc	529.59	126.07B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	649.81	65.37B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	916.80	57.70B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	313.04	40.19B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	189.99	39.82B	742.00K	-1.37B	-1.07B	-7.0731

Rallybio Corp Stock (RLYB) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-09-25	Downgrade	H.C. Wainwright	Buy → Neutral
May-15-24	Downgrade	JP Morgan	Overweight → Neutral
Feb-07-24	Downgrade	Jefferies	Buy → Hold
Apr-17-23	Initiated	H.C. Wainwright	Buy
Apr-10-23	Initiated	Wedbush	Outperform
Dec-09-22	Initiated	JP Morgan	Overweight
Feb-22-22	Initiated	JMP Securities	Mkt Outperform
Aug-23-21	Initiated	Cowen	Outperform
Aug-23-21	Initiated	Evercore ISI	Outperform
Aug-23-21	Initiated	Jefferies	Buy

View All

Rallybio Corp Stock (RLYB) Latest News

Jun 29, 2026

RLYB Stock Hits 2-Year Highs After Unveiling Merger With Avenzo – How Much Of The New Company Will Rallybio Shareholders Own? - Stocktwits

Jun 29, 2026

Rallybio Corporation(NasdaqCM: RLYB) added to Russell Microcap Value Benchmark Index - marketscreener.com

Jun 29, 2026

Rallybio Corporation(NasdaqCM: RLYB) added to Russell Microcap Index - marketscreener.com

Jun 29, 2026

Jun 26, 2026

RLYB stock hits 2-year highs after unveiling merger with Avenzo – how much of the new company will Rallybio shareholders own? - MSN

Jun 26, 2026

What's Driving Rallybio's Recent Surge and Investor Interest - Kavout | AI

Jun 26, 2026

Jun 25, 2026

Rallybio Corporation Actuals & Estimates (NASDAQ:RLYB) - TradingView

Jun 25, 2026

Jun 17, 2026